Causal Relationship between Adiponectin and Metabolic Traits: A Mendelian Randomization Study in a Multiethnic Population

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Mente, Andrew ^a,b   Meyre, David ^a,b   Lanktree, Matthew B ^b,c   Heydarpour, Mahyar ^a   Darlene Davis, A ^e   Miller, Ruby ^e   Gerstein, Hertzel ^a,b   Hegele, Robert A ^c,d   Yusuf, Salim ^a,b   Anand, Sonia S ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e Six Nations Health Services   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CYTOSINE; GLUCOSE; GUANINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADIPOQ GENE; ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CANADA; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; ETHNICITY; GCKR GENE; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENDELIAN RANDOMIZATION ANALYSIS; METABOLIC SYNDROME X; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

ADIPONECTIN; ADULT; AGED; ETHNIC GROUPS; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; MENDELIAN RANDOMIZATION ANALYSIS; METABOLISM; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT, HERITABLE; REGRESSION ANALYSIS;

EID: 84879491823     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066808     Document Type: Article

References (69)

1. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF, (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270: 26746-26749.
2. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98: 2005-2010.
3. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946.
4. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, et al. (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100: 2473-2476.
5. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935.
6. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, et al. (2004) Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43: 1318-1323.
7. Matsubara M, Maruoka S, Katayose S, (2002) Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87: 2764-2769.
8. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, et al. (2003) Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23: 85-89.
9. Yamamoto Y, Hirose H, Saito I, Nishikai K, Saruta T, (2004) Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. J Clin Endocrinol Metab 89: 87-90.
10. Wildman RP, Mancuso P, Wang C, Kim M, Scherer PE, et al. (2008) Adipocytokine and ghrelin levels in relation to cardiovascular disease risk factors in women at midlife: longitudinal associations. Int J Obes (Lond) 32: 740-748.
11. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, et al. (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360: 57-58.
12. Chow WS, Cheung BM, Tso AW, Xu A, Wat NM, et al. (2007) Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 49: 1455-1461.
13. Laughlin GA, Barrett-Connor E, May S, Langenberg C, (2007) Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol 165: 164-174.
14. Vozarova B, Stefan N, Lindsay RS, Krakoff J, Knowler WC, et al. (2002) Low plasma adiponectin concentrations do not predict weight gain in humans. Diabetes 51: 2964-2967.
15. Henneman P, Aulchenko YS, Frants RR, Zorkoltseva IV, Zillikens MC, et al. (2010) Genetic architecture of plasma adiponectin overlaps with the genetics of metabolic syndrome-related traits. Diabetes Care 33: 908-913.
16. Povel CM, Boer JM, Feskens EJ, (2011) Shared genetic variance between the features of the metabolic syndrome: heritability studies. Mol Genet Metab 104: 666-669.
17. Saito K, Tobe T, Minoshima S, Asakawa S, Sumiya J, et al. (1999) Organization of the gene for gelatin-binding protein (GBP28). Gene 229: 67-73.
18. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, et al. (2002) Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11: 2607-26014.
19. Heid IM, Henneman P, Hicks A, Coassin S, Winkler T, et al. (2010) Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 208: 412-420.
20. Croteau-Chonka DC, Wu Y, Li Y, Fogarty MP, Lange LA, et al. (2012) Population-specific coding variant underlies genome-wide association with adiponectin level. Hum Mol Genet 21: 463-471.
21. Warren LL, Li L, Nelson MR, Ehm MG, Shen J, et al. (2012) Deep resequencing unveils genetic architecture of ADIPOQ and identifies a novel low-frequency variant strongly associated with adiponectin variation. Diabetes 61: 1297-1301.
22. Jee SH, Sull JW, Lee JE, Shin C, Park J, et al. (2010) Adiponectin concentrations: a genome-wide association study. Am J Hum Genet 87: 545-552.
23. Wu Y, Li Y, Lange EM, Croteau-Chonka DC, Kuzawa CW, et al. (2010) Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. Hum Mol Genet 19: 4955-4964.
24. Richards JB, Waterworth D, O'Rahilly S, Hivert MF, Loos RJ, et al. (2009) A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet 5: e1000768.
25. Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, et al. (2012) Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 8: e1002607.
26. Laumen H, Saningong AD, Heid IM, Hess J, Herder C, et al. (2009) Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes 58: 984-991.
27. Ong KL, Li M, Tso AW, Xu A, Cherny SS, et al. (2010) Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese. Eur J Endocrinol 163: 251-257.
28. Han LY, Wu QH, Jiao ML, Hao YH, Liang LB, et al. (2011) Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 54: 2303-2314.
29. Yang Y, Zhang F, Ding R, Wang Y, Lei H, et al. (2012) Association of ADIPOQ gene polymorphisms and coronary artery disease risk: A meta-analysis based on 12 465 subjects. Thromb Res 130: 58-64.
30. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, et al. (2000) Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 356: 279-284.
31. Anand SS, Yusuf S, Jacobs R, Davis AD, Yi Q, et al. (2001) Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP). Lancet 358: 1147-1153.
32. Anand SS, Yusuf S, Vuksan V, Devanesen S, Montague P, et al. (1998) The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators. Can J Cardiol 14: 1349-57.
33. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC, (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20: 470-475.
34. McGowan MW, Artiss JD, Strandbergh DR, Zak B, (1983) A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 29: 538-542.
35. Neeley WE, (1972) Simple automated determination of serum or plasma glucose by a hexokinase-glucose-6-phosphate dehydrogenase method. Clin Chem 18: 509-515.
36. Warnick GR, Nguyen T, Albers AA, (1985) Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Clin Chem 31: 217-222.
37. Friedewald WT, Levy RI, Fredrickson DS, (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
38. Wallace TM, Matthews DR, (2002) The assessment of insulin resistance in man. Diabet Med 19: 527-534.
39. Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, et al. (2008) Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One 3: e3583.
40. Timpson NJ, Nordestgaard BG, Harbord RM, Zacho J, Frayling TM, et al. (2011) C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obes (Lond) 35: 300-308.
41. Beer NL, Tribble ND, McCulloch LJ, Roos C, Johnson PR, et al. (2009) The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet 18: 4081-4088.
42. Rees MG, Wincovitch S, Schultz J, Waterstradt R, Beer NL, et al. (2012) Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk. Diabetologia 55: 114-122.
43. Vaxillaire M, Cavalcanti-Proença C, Dechaume A, Tichet J, Marre M, et al. (2008) The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes 57: 2253-2257.
44. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
45. Petrone A, Zavarella S, Caiazzo A, Leto G, Spoletini M, et al. (2006) The promoter region of the adiponectin gene is a determinant in modulating insulin sensitivity in childhood obesity. Obesity (Silver Spring) 14: 1498-1504.
46. Ferguson JF, Phillips CM, Tierney AC, Pérez-Martínez P, Defoort C, et al. (2010) Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. Am J Clin Nutr 91: 794-801.
47. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707-713.
48. Ebrahim S, Davey Smith G, (2008) Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum Genet 123: 15-33.
49. Wagner A, Simon C, Oujaa M, Platat C, Schweitzer B, et al. (2008) Adiponectin is associated with lipid profile and insulin sensitivity in French adolescents. Diabetes Metab 34: 465-471.
50. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, et al. (2002) Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 103: 137-145.
51. Hanley AJ, Connelly PW, Harris SB, Zinman B, (2003) Adiponectin in a native Canadian population experiencing rapid epidemiological transition. Diabetes Care 26: 3219-3225.
52. Goropashnaya AV, Herron J, Sexton M, Havel PJ, Stanhope KL, et al. (2009) Relationships between plasma adiponectin and body fat distribution, insulin sensitivity, and plasma lipoproteins in Alaskan Yup'ik Eskimos: the Center for Alaska Native Health Research study. Metabolism 58: 22-29.
53. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, et al. (2002) Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277: 25863-25866.
54. Combs TP, Pajvani UB, Berg AH, Lin Y, Jelicks LA, et al. (2004) A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145: 367-383.
55. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, et al. (2003) Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278: 2461-2468.
56. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, et al. (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117: 2621-2637.
57. Shetty S, Ramos-Roman MA, Cho YR, Brown J, Plutzky J, et al. (2012) Enhanced fatty acid flux triggered by adiponectin overexpression. Endocrinology 153: 113-122.
58. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-95.
59. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE, (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953.
60. Buzzetti R, Petrone A, Zavarella S, Zampetti S, Spoletini M, et al. (2007) The glucose clamp reveals an association between adiponectin gene polymorphisms and insulin sensitivity in obese subjects. Int J Obes (Lond) 31: 424-428.
61. Perez-Martinez P, Lopez-Miranda J, Cruz-Teno C, Delgado-Lista J, Jiménez-Gómez Y, et al. (2008) Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men. J Nutr 138: 1609-1614.
62. Karmelić I, Lovrić J, Božina T, Ljubić H, Vogrinc Ž, et al. (2012) Adiponectin level and gene variability are obesity and metabolic syndrome markers in a young population. Arch Med Res 43: 145-153.
63. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. (2009) Finding the missing heritability of complex diseases. Nature 461: 747-753.
64. Lin PI, Vance JM, Pericak-Vance MA, Martin ER, (2007) No gene is an island: the flip-flop phenomenon. Am J Hum Genet 80: 531-538.
65. Mente A, Razak F, Blankenberg S, Vuksan V, Davis AD, et al. (2010) Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 33: 1629-1634.
66. Ferris WF, Naran NH, Crowther NJ, Rheeder P, van der Merwe L, et al. (2005) The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res 37: 695-701.
67. Khoo CM, Sairazi S, Taslim S, Gardner D, Wu Y, et al. (2011) Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population. Diabetes Care 34: 1120-1126.
68. Robiou-du-Pont S, Bonnefond A, Yengo L, Vaillant E, Lobbens S, et al. (2012) Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population. Int J Obes (Lond). In press.
69. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, et al. (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42: 937-948.